Molecular Tumor Board
The GO Molecular Tumor Board is a software solution that is designed to automate your Tumor Board processes. By combining our proprietary knowledgebase with your internal patient data, the GO Molecular Tumor Board matches patients to specific treatment recommendations based on their molecular and clinical history.
These recommendations are pulled into the GO Molecular Tumor Board automatically, simplifying the case and presentation creation process, creating a final report to include in a patient's EHR record. With the ability to be implemented on-premise or in the cloud, the GenomOncology Molecular Tumor Board can automate your Tumor Board process and provide relevant, meaningful content to inform a patient's treatment plan.
Enhance clinical decision support in a molecular tumor board setting, or at the point of care.
Solution Features
Variant Information
Evaluate and interpret variant significance from various vendors using our complex biomarker ontology in one view.
Treatment Recommendations
Analyze relevant biomarker-based clinical trial and therapy recommendations that result from the combinations of a patient's prior interventions, molecular variant data, and clinical data.
Curated Clinical Trials
Access all biomarker-based clinical trials curated through our in-house curation team and partnerships with leading content institutions.
Curated Therapy Recommendations
Match patients to biomarker-driven therapies, containing all FDA Approvals and Professional Guidelines and literature from leading content institutions.
Institutional Trial Prioritization
Integrate with clinical trial matching systems to prioritize and match to institutional trials, including up-to-date accrual status.
Partial Match
We provide you with additional trials that match to a patient due to the absence of tested alterations and trials that the patient would be eligible for if variants had been tested for.
Automating Your Workflow
Clinical Data
Integrate with an institution’s clinical data warehouse and EHR to enable the automatic combination of clinical data with molecular data for simplified case creation. This integration also allows for the export of case results back into those client systems.
Molecular Data
Automatically generate cases upon receiving new files from vendors through Secure File Transfer Protocol (SFTP). It differentiates between vendors and assays for comprehensive variant processing.
Final Recommendations
Capture case-level recommendations to be able to export or send out to EHR systems. Our flexible reporting tools enable you to create case summaries, meeting summaries, and Molecular Tumor Board presentations.